N17.92 N17.93
Conditions
Interventions
Group 1: Intervention group: Weigh daily for a period of seven days.
Group 2: Control
Sponsors
Charité Universitätsmedizin BerlinKlinik für Nephrologie und internistische Intensivmedizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: *AKI KDIGO 2 or 3 *No marked haemodynamic instability (noradrenaline up to a maximum of 0.3microg/min, no adrenaline, assessment of the attending physician)
Exclusion criteria
Exclusion criteria: *Failure to obtain patient consent or revocation of same. *Ecmo therapy *Noradrenaline level lower 0,05 microgram/minute
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Daily weighing will give patients a cumulatively lower fluid balance over 7 days after inclusion in the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Daily weighing leads to faster recovery from AKI. Daily weighing leads to fewer dialysis treatments in the first 4 weeks. Daily weighing leads to shorter ITS stay. | — |
Countries
Germany
Contacts
Public ContactPhilipp Enghard
Charité Universitätsmedizin BerlinKlinik für Nephrologie und internistische Intensivmedizin
Outcome results
None listed